A UK ear zapper that reads your heart rate and breathing and adjusts as it goes. A clever idea and a polished app, but no published trial of its own, at £695.
It's ten past seven and you're stirring pasta when your watch buzzes: high heart rate, while you're standing still. Again. Later, in bed, an ad shows a sleek white earpiece that promises to read your body and calm it in ten minutes a day. Personalised, it says.
That word is doing a lot of work.
SONA hooks over your ear like a wireless headset. You brush conductive gel onto its two small electrodes with an included pen, slot it on, and open the free app, which rates your contact. One electrode presses into the cymba concha, the hollow above your ear canal. The other sits at the tragus, the flap in front of it.
You set a session length, a breathing pace and an intensity from 1 to 20, and watch your heart rate, heart rate variability (HRV) and breathing live. Marketing says 10 minutes a day; SONA's team has mentioned 10 to 40. Reviewers describe a fizz or tickle; set too high, it pinches.
"Personalised," per SONA, means the app builds a program around your goal, an algorithm adjusts the waveform and timing to your HRV and breathing, and over weeks it learns what you respond to. SONA doesn't publish its frequencies or current. For ear versus neck devices, see the Zappers.
Mostly, yes. In the most-cited dissection study, of 14 ears, the vagus branch reached the cymba concha in every one, so SONA's main electrode is in the right place. It reached the tragus in fewer than half.
The sensing is the new part, and a reasonable idea. Nobody has yet shown that adjusting stimulation to your HRV and breathing beats a fixed setting for stress or sleep.
On SONA itself, we found no published trial and nothing on ClinicalTrials.gov. Its research is early:
That last number needs context: sessions come with a slow-breathing pacer, and slow breathing raises HRV by itself. The site's bigger promises, "HRV up to 2× baseline" and 30 to 40 extra minutes of deep sleep a night, come with no source we could find.
The studies SONA cites test other devices at other doses. They include the Czech sleep trial (68 adults), which SONA itself calls inconclusive against sham, and the 2024 insomnia trial (72 people, mostly women in their mid-40s), where the sham group improved about half as much as the real one, on about four times SONA's weekly dose.
The wider picture. Ear stimulation's strongest results are in hearts, like the NIH-funded Oklahoma trials in atrial fibrillation and POTS. For stress and sleep, it's promising but early, and expectation does a lot of work. More on reading studies in the Science.
Orders began arriving around March 2026, after long delays. As of October 2026, SONA scores 4.3 on Trustpilot from 53 reviews (79% five-star, 11% one-star), mostly from the UK, and it invites reviews. The iPhone app has 4.1 stars from 7 UK ratings.
The good
The not so good
Prices as of October 2026:
Only SONA reads your body while it works. It's also the newest and least tested.
We found no contraindications list from SONA. Its terms say to ask your doctor first if you have a pre-existing condition or an implant such as a pacemaker; its blog adds epilepsy and pregnancy.
A better guide is that NHS tinnitus study. It excluded people with a pacemaker or other implant, epilepsy, heart disease, a slow heart rhythm or past heart attack, pregnancy, asthma or COPD, Raynaud's or ear skin problems, and people taking beta blockers. I'd treat that as the minimum. Note the last one: plenty of midlife women take beta blockers for palpitations or migraine.
If a racing heart is new, especially since perimenopause, get it checked before blaming stress. A device can sit alongside treatment, HRT included, but it can't replace a diagnosis.
SONA's own breathing research landed on about five breaths a minute. Try it tonight, free: lie down and breathe in for five counts, out for seven, for ten minutes. A 2022 review of 223 studies found slow breathing raises the heart rate variability linked to your vagus nerve. More free options are in the Analogs.
Some owners say it helps their sleep and anxiety; others notice nothing. SONA has no published trial, and its personalisation is untested.
Yes. It ships from the UK, at about $941 as of October 2026. It isn't FDA-cleared, returns go back to the UK, and we found no HSA/FSA option.
No. SONA calls it a "non-medical wellness device" with CE and UKCA marks, which here cover things like electrical safety, not health claims.
Nurosym has far more research and a 2-year warranty, but no app and long sessions. SONA is quicker, reads your body and costs about £100 more in the UK. For evidence, Nurosym. For data and design, SONA, with the return window as your safety net.
SONA is the most ambitious ear device we've looked at: real-time sensing, a thoughtful app and an unusually open team. But "personalised" is a design idea, not a proven result, and early owners have faced fit problems and long waits.
If £695 won't hurt, I'd treat it as a 30-day experiment: get a firm ship date, use it daily, keep the box, and decide by week three. Keep the slow breathing going either way. It fits every ear.
The over-the-counter sibling of a prescription headache device. Two-minute neck sessions, real engineering, thin evidence for stress and sleep, and a refund with fine print.
An ear clip with more published research than other ear devices, mostly in heart conditions. The stress and sleep numbers are thinner than the homepage suggests, and it isn't sold in the US.
Earbuds that send a gentle current into your left ear. Discreet and liked by many owners, but fiddly to set up, and its boldest sleep stats come from in-house pilots.